A randomized phase III trial comparing two dose-dense, dose-intensified approaches (EPC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto).

作者:Schneeweiss Andreas; Moebus Volker; Blohmer Jens Uwe; Costa Serban Dan; Denkert Carsten; Eidtmann Holger; Hanusch Claus; Hilfrich Joern; Huober Jens Bodo; Jackisch Christian; Paepke Stefan; Kuemmel Sherko; Tesch Hans; Untch Michael; Loibl Sibylle; Von Minckwitz Gunter
来源:Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2015-05-29 to 2015-06-02.
  • 出版日期2015-5-20